Onco-Vac Biopharma Private Limited
About Onco-Vac Biopharma Private Limited
Data last updated:
Onco-Vac Biopharma Private Limited is a private limited company based in Delhi, India. It operates in the scientific research segment of the research and development sector. It was incorporated on 16 September 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U73100DL2022PTC404697.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Raj Kumar Mallick and Ashok Kumar Vaid.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 3/53 T/F Janakpuri, Delhi, India – 110058.
As per the financials filed for FY 2025, the company reported a revenue of ₹28,383, a decline of 98% compared to the previous year. For the same year it recorded a net loss of ₹1.54 Lakh and EBITDA of -₹1.54 Lakh.
Company details
Contact details
Onco-Vac Biopharma Private Limited's registered office is in Delhi, Delhi.
- Registered AddressB – 3/53 T/F Janakpuri, Delhi, India – 110058
- IndustryResearch & Development, Science Research
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Onco-Vac Biopharma is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Onco-Vac Biopharma Private Limited, buy the company report.
Financials of Onco-Vac Biopharma Private Limited
FY 2025 filings availableOnco-Vac Biopharma Private Limited reported revenue of ₹28,383 (down 98% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 98% in the latest year. EBITDA fell 112% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹1.54 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹1.54 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Onco-Vac Biopharma Private Limited, buy the company report.
Board of directors of Onco-Vac Biopharma Private Limited
Onco-Vac Biopharma has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raj Kumar Mallick Also directs: Aureate Healthcare Limited, Bravo Infotech India Pvt. Ltd., Pharmamen Logistics Private Limited and 1 more | Director | 16 Sep 2022 | 4 Years 1 Months | Current |
| Ashok Kumar Vaid | Director | 16 Sep 2022 | 4 Years 1 Months | Current |
| Ram Vishwakarma Asrey | Director | 10 Feb 2023 | 3 Years 9 Months | Current |
| Anant Vishwakarma | Director | 14 Nov 2022 | 3 Years 11 Months | Current |
Legal cases
No court or tribunal cases involving Onco-Vac Biopharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Onco-Vac Biopharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Onco-Vac Biopharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Onco-Vac Biopharma Private Limited has 4 board changes on record since 2022: 4 appointments. The latest: Ram Vishwakarma Asrey was appointed as Director on 10 Feb 2023.
Frequently asked questions
Onco-Vac Biopharma is an active private limited company based in Delhi, India. The company works in science research, within the research and development industry. It was incorporated on 16 September 2022 (4+ years old) and is registered under CIN U73100DL2022PTC404697.
Onco-Vac Biopharma has 4 current directors:
- Raj Kumar Mallick - Director
- Ashok Kumar Vaid - Director
- Ram Vishwakarma Asrey - Director
- Anant Vishwakarma - Director
The latest financial statements of Onco-Vac Biopharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Onco-Vac Biopharma is U73100DL2022PTC404697. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Onco-Vac Biopharma was incorporated on 16 September 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
Ram Vishwakarma Asrey was appointed as Director on 10 Feb 2023. Anant Vishwakarma was appointed as Director on 14 Nov 2022. Ashok Kumar Vaid was appointed as Director on 16 Sep 2022. Onco-Vac Biopharma has 4 board changes on record in total.
The registered office of Onco-Vac Biopharma is at B – 353 TF Janakpuri, Delhi, India – 110058.
Onco-Vac Biopharma operates in the research and development industry, in the science research segment.
Onco-Vac Biopharma can be reached at its registered office: B – 353 TF Janakpuri, Delhi, India – 110058.
Onco-Vac Biopharma is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
